Lubosan, Edie L.
HRN: 26-03-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/11/2024
10/18/2024
IV
1.5 Grams
Q8H
Acute Tonsillopharyngitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes